← Oncology Approval Tracker

FDA DECISION ·

Pemfexy multidose vial

pemetrexed · Eagle Pharmaceuticals

FDA approvalNew formulationNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Authorized multidose use of the 500 mg/20 mL Pemfexy vial for its already approved nonsquamous NSCLC and malignant pleural mesothelioma indications.

LAMPGEN ANALYSIS

Why it matters

Changed the approved vial presentation without changing which cancer populations could receive it.

What research teams should watch

Update multidose handling, storage and discard instructions in pharmacy procedures.

PRIMARY RECORDS

Sources